Park Ha Biological Technology is trading 6.03% down at $2.18, with no verified October 26, 2026 company announcement or new catalyst explaining the decline.
- A class-action notice surfaced with an October 26 update, but its underlying July press release concerns alleged conduct from an earlier period and does not establish a new cause.
- The broader market is higher; available evidence does not indicate the stock is following its direction, and no clear company-specific or market-wide driver is confirmed.